Coronavirus: First vaccinations could take place next month, official says

Henrietta Brewer
November 23, 2020

Dr. Moncef Slaoui, chief of Operation Warp Speed, the initiative which is managing the Trump administration's coronavirus vaccine development efforts, predicted Sunday that life could return to normal around May as Americans begin receiving vaccinations against the coronavirus.

Operation Warp Speed chief advisor Dr Moncef Slaoui.

The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of U.S. drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account on Sunday.


The US-based pharma giant will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

Also read: Pfizer seeking emergency use of its COVID-19 vaccine in U.S. Each state will decide who gets the vaccine first with the recommendation that priority be given to health care workers, front-line workers and the elderly who face the highest risks of dying from the virus.

As new COVID-19 cases continue to surge, millions of Americans are ignoring federal and state warnings to stay home for Thanksgiving to prevent overwhelming already strained hospitals. Russian Federation became the first country to register the world's first COVID-19 vaccine on August 11.


Last week Mr Biden called the vaccination program a "massive undertaking" and "one of the greatest challenges we will face as a nation". A Gallup poll from Tuesday showed that 58 percent of Americans said they would get a coronavirus vaccine and 42 percent said they wouldn't. "What we do need is we need to get as many people as possible vaccinated". Slaoui said the White House's plan is to inoculate 20 million people in December, and then as many as 30 million each following month.

Earlier this month, developers of Sputnik V, RDIF and Gamaleya Institute, announced interim data from a large trial suggests the shot appears to be 92% effective.

The number of United States coronavirus cases has surpassed 12 million and rose by more than 1 million cases in less than a week for the first time.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER